Erythromycin was found to be a more effective inhibitor of gram-negative bacilli in alkaline medium than in neutral or acid medium. A definite effect was noted with all of 500 recent clinical isolates of Escherichia coli, Klebsiella-Enterobacter, Pseudomonas aeruginosa, and Proteus mirabilis studied, but it was most striking with E. coli. At pH 8.5 all strains, except for 14% of those of P. mirabilis, were inhibited by concentrations of erythromycin readily achieved in urine with common therapeutic doses.
Studies on streptomycin (1, 7) and later on erythromycin (3) indicated that their antibacterial activities vary markedly with the pH of the medium; these two antibotics have significantly lower minimal inhibitory concentrations (MIC) at high pH than in medium with neutral or low pH. The pH effect on erythromycin activity was first demonstrated against Streptococcus pyogenes and Sarcina lutea (3) and later against staphylococci (2). It was shown that alkaline pH also enhances the activity of erythromycin against gram-negative organisms (6, 9) . Zagar (9) (5) . Ten strains of E. coli were also tested at several pH intervals between pH 5.5 and 8.0 to determine more precisely the point at which the antibacterial activity of erythromycin shows the greatest change. Both the MIC and the minimal bactericidal concentration (MBC) were determined by using techniques and criteria previously described (5). The erythromycin used was generously supplied by Eli Lilly & Co., Indianapolis, Ind.
RESULTS
The results (Table 1) indicate that at pH 8.5 all the strains of E. coli were inhibited by 3.12 ,ug of erythromycin per ml, a concentration easily attainable in urine with therapeutic doses of erythromycin. The strains of KlebsiellaEnterobacter were less sensitive. Only 60% of them were inhibited by 3.12 ,ug of erythromycin per ml, but 95% were inhibited by 12.5 ,ug/ml, a concentration also readily achieved in urine (4, 10). Most strains of Pseudomonas were more resistant, but 12 of those tested were sensitive to 6.25 ,ug/ml and all were inhibited by 50 ,ug/ml, a concentration achieved in urine by all subjects taking 3.0 g of erythromycin estolate in 24 hr (4). All strains of Proteus were resistant to 12.5 ,gg/ml, but 90% of them were inhibited by 100 ,ug/ml or less, concentrations found in the urine of some subjects during therapy (4).
The results (Fig. 1A) indicate that between pH 6 and 7 the inhibitory activity of erythromycin increases sharply. Further increase in activity was also noted up to pH 8. The effect of pH on the MBC did not parallel the effect on MIC; for 4 of the 10 strains studied, the MBC was identical at pH 5.5 and 8 (Fig. 1B) . (8) tested 347 strains of E. coli and found 50% of the strains were inhibited by 10 ,ug of erythromycin per ml (pH 6). The strains reported here showed greater resistance; none were inhibited by 10 Ag/ml, even at pH 7. However, they were much more sensitive in alkaline medium. In a small clinical study, Zinner et al. (10) found that 71%o of 24 patients cleared their urine of bacteria with erythromycin-alkali treatment. The results of the present study suggest that most isolates of E. coli and Klebsiella-Enterobacter from patients with bacteriuria might be expected to be sensitive to erythromycin in sufficiently alkaline urine. Because strains of Pseudomonas and especially Proteus had higher MIC, even in alkaline urine, larger doses of erythromycin would appear to be indicated for therapeutic trials of urinary tract infections due to those organisms. Nevertheless, alkalinization of the medium clearly increased the antibacterial activity of erythromycin against virtually all the strains studied. 
